The functional genomic studies of resveratrol in respect to its anti-cancer effects
- PMID: 29476886
- DOI: 10.1016/j.biotechadv.2018.02.011
The functional genomic studies of resveratrol in respect to its anti-cancer effects
Erratum in
-
Corrigendum to "The functional genomic studies of resveratrol in respect to its anti-cancer effects" [Biotechnol Adv. 2018 Nov 1;36(6):1699-1708].Biotechnol Adv. 2020 Mar-Apr;39:107482. doi: 10.1016/j.biotechadv.2019.107482. Epub 2019 Dec 12. Biotechnol Adv. 2020. PMID: 31839208 No abstract available.
Abstract
Resveratrol has anti-cancer effects in vitro, and hypothetical chemopreventive effects in vivo. Effects are pleiotropic, mediated by changes in expression of many genes and epigenetic reprogramming. Thus, they are well suited for functional genomic studies. We carried out systematic review of such studies (reflecting also on technological progress). Differentially expressed genes commonly linked to resveratrol treatment were linked to cell cycle, proliferation, and apoptosis. However, it is unclear if these are primary and specific targets of resveratrol. We conclude by discussing areas where additional functional genomic studies are desirable, including experiments that better model in vivo effects of dietary intake.
Keywords: Apoptosis; Cancer; Functional genomics; Microarrays; Proliferation; Resveratrol.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
